The salford lung study was a clinical trial which began recruitment in 2012, with the basis that enrolment would be open to a much broader population with a diagnosis of chronic obstructive pulmonary disease copd or asthma in the region, regardless of whether or not they had other conditions such as cancer or high blood pressure. The salford lung study sls was a worldfirst, prospective, phase iii, pragmatic randomised controlled trial rct programme in patients with chronic obstructive pulmonary disease and asthma to. Study of an experimental drug in asthma and copd 7 7000 patients from a single city well defined nhs area with a strong academic centre minimal exclusion criteria active recruitment resource randomised, open label design, 1 year follow up free choice mixed comparator arm. Positive results from pioneering salford lung study in asthma. Sep 04, 2016 a second salford lung study is currently being conducted in patients with asthma, with results expected in 2017. Evidence notes issue seven june 2016 issue seven june.
This paper describes the hurdles overcome and the enormous effort and resource required to establish this comparative effectiveness study of a prelicence intervention. Patient demographics and clinical characteristics in the uk. In this post hoc analysis of the salford lung studies in copd and asthma two 12month, openlabel, effectiveness. This was the first effectiveness rct of its kind in uk primary care with broad inclusion criteria. Consent in the salford lung study the process of consent and randomisation was supported by study staff consent forms were available in different languages and in audio format consent was obtained by the patients gp in their usual practice some sites used study nurses to take patients through the consent process.
And i was one of the leads on the salford lung study. Costconsequence analysis of fluticasone furoatevilanterol for asthma management in spain. Evidence notes issue seven june 2016 3 according to the authors, the salford lung study in asthma and copd is worlds first preapproval phase iii randomised pct21 and, although ongoing, is a useful case study to explore. This was the first effectiveness rct of its kind in uk primary care with. Relvar ellipta significantly improved asthma control in. The salford lung study is important as one of the first clinical effectiveness studies. The salford lung study in asthma sls asthma is a 12month, openlabel randomised clinical trial comparing clinical effectiveness of initiating oncedaily inhaled combination of fluticasone furoatevilanterol ffvi 18422 mcg or 9222 mcg, with continuing optimized usual care uc with inhaled corticosteroids ics alone, or in combination with a. Effectiveness of fluticasone furoatevilanterol versus fluticasone propionatesalmeterol on asthma control in the salford lung study. The results of the successful asthma arm of the salford lung study sls have been announced. Sep 11, 2017 the salford lung study is important as one of the first clinical effectiveness studies of its kind, providing interesting insights into the management of asthma in clinical care. Sls copd was a 52week, prospective, comparative, openlabel, randomised controlled trial rct conducted in the city of salford in the uk. Impact of socioeconomic status on participation and. Salford lung study reports successful asthma trial research.
Patientreported outcomes with initiation of fluticasone furoatevilanterol versus continuing usual care in the asthma salford lung study henrik svedsater. Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice. The salford lung study is a phase iiib multicentre, open label. Sls will evaluate the effectiveness and safety of the ffvi combination compared with existing maintenance therapy in a large, realworld population of patients with copd in conditions of normal care.
Effectiveness of fluticasone furoatevilanterol for copd in. Effectiveness of fluticasone furoatevilanterol for copd. We did an openlabel, randomised, controlled, twoarm effectiveness trial at 74 general practice clinics in salford and south manchester, uk. The salford lung study sls of patients with asthma and chronic obstructive pulmonary disease copd is a practical, communitybased, randomized, openlabel pragmatic study on the efficacy and safety of the oncedaily dry powder inhaler that combines the inhaled corticosteroid fluticasone furoate ff with the longacting beta 2. Positive results from pioneering salford lung study in. Dec 15, 2017 the salford lung study in copd sls copd was a clinical trial conducted in a uk primary care population that was designed to be representative of patients with copd in routine clinical practice. The study involved over 2,800 consenting patients, supported by 80 gp practices and pharmacies in salford and the surrounding greater manchester area. Salford lung study in chronic obstructive pulmonary disease. Use of patients linked electronic health records to collect clinical endpoints offers minimal disruption to patients and investigators, and also ensures patient safety.
Salford lung study in chronic obstructive pulmonary. Study investigating the generalisability of a copd trial. Global initiative for asthma, gina 106 are almost entirely based on efficacy rcts in highly selected and closely monitored patient 107 populations. Using an electronic medical record emr to conduct clinical. Research article open access using an electronic medical record emr to conduct clinical trials.
An effectiveness study comparing fluticasone furoate ff. Relvar elliptasignificantly improved asthma control in. Dec 10, 2015 the salford lung study is the worlds first pragmatic randomised controlled trial of a prelicensed medication in asthma. Healthcare professionals from eight organisations across greater manchester have collaborated to deliver the initial results of the salford lung study sls. The salford lung study is important as one of the first clinical effectiveness studies of its kind, providing interesting insights into the management of asthma in clinical care. The salford lung study is the worlds first phase iii prct in asthma and chronic obstructive pulmonary disease copd, which aims to randomise over 7000 patients. Effectiveness of fluticasone furoatevilanterol versus. Relvar ellipta salford lung study sls pioneering asthma study results. Salford lung study in asthma free download as pdf file. We now report the results of the salford lung study on asthma, which compared the effectiveness of the. Oct 15, 2012 jacques l, bakerly nd, new jp, svedsater h, layflurrie j, leather da. At week 24, the odds of patients being act responders total score. The study was initiated before this investigational.
Sls asthma is the worlds first large prospective asthma effectiveness randomised controlled trial rct. Challenges and complexities with the reporting of electronic medical record data in a pioneering phuse 2018, frankfurt 6 and novel approach to clinical trials manchester london salford randomised openlabel, parallel group design 12. Impact of socioeconomic status on participation and outcomes. The salford lung study sls programme, encompassing two phase iii pragmatic randomised controlled trials, was designed to generate evidence on the effectiveness of a once. Effectiveness of fluticasone furoatevilanterol in asthma. The salford lung studies sls are groundbreaking trials designed to study the effectiveness and safety of initiating treatment with relvar ellipta in patients with asthma and copd versus existing continuing maintenance therapy. Salford lung study asthma results published northwest. Set in salford and southern manchester districts, uk the sls asthma study rw01. The salford lung study is intended to enable healthcare professionals and decision makers to more fully assess the potential value of ffvi by providing data collected in a normal clinical. Aug 15, 2019 the salford lung study in asthma sls asthma was a multicentre, randomised, controlled, openlabel trial that assessed initiating oncedaily, singleinhaler fluticasone furoatevilanterol ffvi. The highly anticipated results from the salford lung study were announced by gsk on 5th may 2017. The study generated effectiveness and safety data for relvar fluticasone furoatevilanterol ffvi, 9222 mcg in a population of patients with copd.
Salford lung study asthma results published northwest ehealth. The salford lung study is a pragmatic randomised controlled trial in adult asthma, evaluating the clinical effectiveness and safety of oncedaily fluticasone furoate 100. A descriptive followup interview study assessing patient. Relvar ellipta significantly improved asthma control in salford lung study patients compared with their usual care. Lung study in asthma that are being presented and published today showing that relvar ellipta was superior to usual care treatment in improving asthma control. Subjects in the sls originally consented for information relevant to the study to be shared with the sponsor gsk. The salford lung study had minimal exclusion criteria and involved a broad demographic of patients. Salford lung study in asthma relvar ellipta fluticasone. Hru data were captured remotely in realtime via pts electronic health records. The salford lung study sls subjects represent a group of copd and asthma patients whose disease is extremely wellcharacterised over a short time period. We now report the results of the salford lung study on asthma, which compared the effectiveness of the fluticasone furoate and. Salford lung study reports successful asthma trial. A second salford lung study is currently being conducted in patients with asthma, with results expected in 2017.
The salford lung study in copd reported findings in may 2016. The salford lung study in copd sls copd was a clinical trial conducted in a uk primary care population that was designed to be representative of patients with copd in routine clinical practice. Effectiveness of fluticasone furoate plus vilanterol on. The salford lung study sls of patients with asthma and chronic obstructive pulmonary disease copd is a practical, communitybased, randomized, openlabel pragmatic study on the efficacy and. The salford lung study sls programme, encompassing two studies, is a pre. What im going to be talking about, is a little bit about the background of this study, why we did it, a little about how we did it, and also tell you a bit about the results, and some of the outcomes from this study. The sls, sponsored by gsk, examined the safety and effectiveness of a new treatment for chronic obstructive pulmonary disease copd and asthma. This study develops novel methods to evaluate the presence of a hawthorne effect operating for a trial, such as the salford lung study in copd, which was conducted in the setting of everyday clinical practice. Salford lung study in asthma clinical trial randomized. Jan 11, 2020 the salford lung study sls was a worldfirst, prospective, phase iii, pragmatic randomised controlled trial rct programme in patients with chronic obstructive pulmonary disease and asthma to evaluate the effectiveness of a prelicensed medication fluticasone furoatevilanterol in realworld practice using electronic health records and. However these efficacy rcts have limited relevance to everyday clinical 108 practice, and so there has been a call for comparative. Asthma is a chronic lung disease that inflames and narrows the airways. Today im going to be talking about the salford lung study, in copd. The salford lung study is a pragmatic randomised controlled trial in adult asthma, evaluating the clinical effectiveness and safety of.
The salford lung study 5 104 research in context 105 guidelines for the routine management of asthma e. The salford lung study on copd5 showed that, compared with continuation of usual care, initiation of the oncedaily combination of fluticasone furoate and vilanterol reduced moderate and severe exacerbations. Respiratory medicine vol 141, pages 1206 august 2018. The salford lung study on copd 5 showed that, compared with continuation of usual care, initiation of the oncedaily combination of fluticasone furoate and vilanterol reduced moderate and severe exacerbations.
Salford lung study feasibility hanaa f elkhenini1,2, kourtney j davis3,4, norman d stein1,2, john p new1,2, mark r delderfield1,2, martin gibson1,2. The salford lung study was designed to evaluate the effectiveness and safety of the oncedaily inhaled combination of fluticasone furoate and vilanterol fluticasone furoatevilanterol as. This is the second of the two salford lung studies to report. Pioneering gsk study provides important new data on the effectiveness of relvar ellipta ffvi when used in everyday clinical practice. The asthma salford lung study demonstrated the effectiveness of initiating oncedaily fluticasone furoatevilanterol ffvi versus continuing usual care in asthma patients in uk primary care 1 woodcock a, vestbo j, bakerly nd, new j, gibson jm, mccorkindale s, jones r, et al. The usual way of investigating new medicine is to use a double blind, randomised controlled trial rct the gold. Copd and asthma prevalence is associated with socioeconomic status or deprivation, yet deprivation is rarely considered in typical largescale efficacy randomised controlled trials that recruit highly selected patient populations. The salford lung study sls of patients with asthma and chronic obstructive pulmonary disease copd is a practical, communitybased, randomized, openlabel pragmatic study. Patient demographics and clinical characteristics in the. The salford lung study sls is the worlds first pragmatic rct prct of an investigational medication. Introduction and objectives the salford lung study in asthma, an openlabel, randomised controlled trial, evaluated the effectiveness of initiating oncedaily inhaled fluticasone furoatevilanterol ffvi versus continuing usual care uc in a large, realworld population of patients with asthma in uk primary care. The salford lung study in asthma sls asthma was a multicentre, randomised, controlled, openlabel trial that assessed initiating oncedaily, singleinhaler fluticasone furoatevilanterol ffvi.
Positive results from the copd salford lung study published. Patients aged 18 years or older with a general practitioners diagnosis of symptomatic asthma and on maintenance inhaler therapy were randomly assigned to initiate treatment with a oncedaily inhaled combination of either 100. Study design the salford lung study is a phase iii multicentre, open label randomised controlled trial rct. Effectiveness in asthma control real world evidence. In this post hoc analysis of the salford lung studies in copd and asthma two 12month, openlabel, effectiveness randomised controlled trials conducted in. Sls copd nct015517581 was a 12month, openlabel, randomised controlled trial rct that evaluated the effectiveness and safety of initiating fluticasone furoatevilanterol 10025g vs continuing usual care in copd patients pts with exacerbation exa history vestbo et al. Anonymised individual participant data from this study plus the annotated case report form, protocol.
395 1079 1252 612 481 984 577 949 50 1215 1061 523 1372 902 1003 121 51 194 1255 763 184 314 676 531 1032 256 386 705 331 490 916 485 1271 923 897 174 700